000 06023nam a22005295i 4500
001 978-94-007-2894-3
003 DE-He213
005 20140220083343.0
007 cr nn 008mamaa
008 120220s2012 ne | s |||| 0|eng d
020 _a9789400728943
_9978-94-007-2894-3
024 7 _a10.1007/978-94-007-2894-3
_2doi
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a614.5999
_223
100 1 _aHayat, M.A.
_eeditor.
245 1 0 _aTumors of the Central Nervous System, Volume 7
_h[electronic resource] :
_bMeningiomas and Schwannomas /
_cedited by M.A. Hayat.
264 1 _aDordrecht :
_bSpringer Netherlands,
_c2012.
300 _aXXXV, 359p. 67 illus., 35 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aTumors of the Central Nervous System ;
_v7
505 0 _aMENINGIOMAS -- Molecular Genetics -- 1. Meningiomas: Role Of Semaphorin3a Protein In Antiangiogenesis -- 2. Meningiomas: Role Of Carbonic Ahydrase Ii -- 3. Meningiomas: Role Of Genetic Instabilities Of The E- Cadherin Gene -- 4. Intracranial Meningiomas: Role Of Exogenous Hormones -- 5. Meningiomas: Clinical Needs And Molecular Insights -- 6. Meningioma: Urokinase Plasminogen Activator -- 7. Mir-200a Regulation Of The Wnt Signaling In Meningioma Tumorigenesis -- Diagnosis -- 8. Meningiomas: Determination Of Subtypes Using Perfusion Magnetic Resonance Imaging -- 9. Intracranial Meningioma In Mice: Noninvasive Bioluminescence Imaging -- 10. Incidentally Discovered Meningiomas: Growth Rates And Patterns -- 11. Cycstic Papillary Meningioma: Diagnosis -- 12. Meningioma Tumors: Detection Of Subgroups -- 13. Prognostic Parameters In Atypical And Malignant Meningiomas -- 14. Sporadic Meningioangiomatosis: Diagnosis With Computed Tomography And Magnetic Resonance Imaging Therapy -- 15. Atypical Meningioma: Distinguishing Features And Role Of Adjuvant Radiation -- 16. Gamma Knife Radiosurgery For Benign Meningioma: Significance And Therapeutic Potential -- 17. Oncocytic Meningioma: Neurosurgery -- 18. Intracranial Meningiomas: Treatmnent And Quality Of Life -- 19. Cavernous Sinus Meningiomas: Optimal Treatment --  Recurrence -- 20. Genetic And Clinical Features Associated With Recurrence In Atypical Meningioma -- 21. Recurrence And Progression In Meningiomas -- 22. Meningioma: Role Of Erythropoietin Receptor In The Tumor Recurrence -- SCHWANNOMAS -- Molecular Genetics -- 23. Cyclin D1 Expression In Vestibular Schwannoma -- 24. Schwannomas: Role Of Molecular Genetics And Epigenetic  Mechanisms -- Diagnosis -- 25. Facial Nerve Schwannoma: Diagnosis Using Magnetic Resonance Imaging -- 26. Vestibular Schwannoma: Optimizing Tumor Growth Monitoring By Volume Measurements -- 27. Intermediate Nerve Schwannomas -- Therapy -- 28. Vestibular Schwannoma, Radiosurgery And Hydrocephalus -- 29. Solitary Vestibular Schwannoma: Decision Making Of Treatments -- 30. Stereotactic Radiosurgery For Trigeminal Schwannoma: Tumor Control And Functional Preservation -- 31. Vestibular Schwannoma: Gamma Knife Radiosurgery -- 32. Vestibular Schwannoma: Gamma Knife Radiosurgery (Method) -- 33. Vestibular Schwannoma Surgery: Use Of Fat Implant To Prevent Cerebrospinal Fluid Fistula -- 34. Retrosigmoidal Craniotomy For Vestibular Schwannoma Patients: Postoperative Cerebrospinal Fluid Leak -- 35. Vestibular Schwannoma Surgery: Histological Considerations And Operative Results -- 36. Vestibular Schwannomas: Treatment With Bevacizumab -- 37. Management Of Vestibular Schwannoma Patients: Quality Of Life Outcomes After Treatment.
520 _aThis seventh volume of the essential series covering practices and developments relating to CNS tumors zeroes in on those found in the brain. Detailed dossiers on meningioma and schwannoma tumors cover aspects including diagnosis, therapy and prognosis. The text delivers vital insights into the molecular pathways related to brain tumor biology, including a detailed analysis of the roles played in neoplasm formation by E-cadherin gene instability, carbonic anhydrase 11, urokinase plasminogen activator, and Wnt signaling. Further research into their influence in the process could prompt the development of effective anti-cancer drugs.   The contributions also show how perfusion magnetic resonance imaging helps physicians differentiate between subtypes of meningiomas, and analyze the influence of molecular genetics and epigenetic mechanisms on schwannoma tumors. Among the diagnostic processes outlined are those for recognizing incidentally discovered meningioma, cystic papillary meningioma, facial nerve schwannoma, vestibular schwannoma, and intermediate nerve schwannoma. This book presents treatments for atypical, oncocytic, intracranial, and cavernous meningiomas, as well as guides to therapeutic methods ranging from neurosurgery and gamma-knife radiosurgery to vestibular schwannoma interventions such as retrosigmoidal craniotomy and immunotherapy. This authoritative volume once again provides invaluable and tightly focused source material for medical professionals committed to placing the latest theories and techniques at the service of those they care for.
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aMedical laboratories.
650 0 _aDrug interactions.
650 0 _aNeurosciences.
650 0 _aRadiology, Medical.
650 1 4 _aBiomedicine.
650 2 4 _aCancer Research.
650 2 4 _aLaboratory Medicine.
650 2 4 _aDrug Resistance.
650 2 4 _aNeurosciences.
650 2 4 _aDiagnostic Radiology.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789400728936
830 0 _aTumors of the Central Nervous System ;
_v7
856 4 0 _uhttp://dx.doi.org/10.1007/978-94-007-2894-3
912 _aZDB-2-SME
999 _c104601
_d104601